LATS2 and breast cancer: Mechanically, it is observed that after treatment with CAF-derived exosomes, miR-92 expression in breast cancer cells was increased significantly, as the target gene of miR-92, LATS2, was downregulated, which subsequently enhanced the nuclear translocation of YAP1.